Buy TREMFYA ONE-PRESS 100 MG GUSELKUMAB

TREMFYA ONE-PRESS 100 MG is a subcutaneous solution containing guselkumab. This medication is designed for specific therapeutic uses, including moderate to severe plaque psoriasis. Learn more about its benefits and how it works.

Strength

100 MG

Manufacturer / TM Owner

JANSSEN INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

TREMFYA ONE-PRESS 100 MG is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. This medication targets specific proteins involved in the inflammatory process, helping to reduce the symptoms associated with psoriasis. What is TREMFYA ONE-PRESS used for? It is indicated for managing chronic skin conditions where other treatments may not have been effective.

Side Effects

Common effects of TREMFYA ONE-PRESS 100 MG may include reactions at the injection site, such as redness, itching, or swelling. Some individuals might experience headaches, fatigue, or upper respiratory infections. These effects are generally mild and temporary, but it's important to monitor any persistent or severe reactions.

Precautions & Warnings

Before using TREMFYA ONE-PRESS 100 MG, inform your healthcare provider about any allergies or medical conditions. This medication should be stored properly and used as directed. Always follow the instructions for subcutaneous administration to ensure safety and effectiveness. Avoid sharing this medication with others.

Avoid Interactions

TREMFYA ONE-PRESS 100 MG may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of this medication.

References

Frequently Asked Questions

TREMFYA ONE-PRESS 100 MG is used for the treatment of moderate to severe plaque psoriasis in adults.

TREMFYA ONE-PRESS 100 MG is administered subcutaneously, typically by injection.

Common side effects may include injection site reactions, headaches, fatigue, and upper respiratory infections.

It is important to consult with a healthcare provider before using TREMFYA ONE-PRESS 100 MG with other medications to avoid potential interactions.

TREMFYA ONE-PRESS 100 MG should be stored according to the instructions provided, typically in a cool, dry place.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.